title: American Society of Clinical Oncology-39th Annual Meting. HRPC and NSCLC. 31 May-3 June 2003, Chicago, IL, USA.
authors.affiliation: Thomson Current Drugs, London, UK. rebecca.erlich@current-drugs.com
authors.forename: Rebecca
authors.initials: R
authors.lastname: Erlich
authors.forename: Anna
authors.initials: A
authors.lastname: Durrance
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D015394:Molecular Structure; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome